Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease

References

• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9
   PubMedGoogle Scholar
• Bhandari A, Bhandari V. ‘‘New’’ bronchopulmonary dysplasia: a clinical review. Clin Pulmon Med 2011;18:137–43
   Google Scholar
• Bhandari A, Bhandari V. Pitfalls, problems and progress in bronchopulmonary dysplasia. Pediatrics 2009;123:1562–73
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443–56
   PubMed Web of Science ®Google Scholar
• Jobe AH. What in BPD in 2012 and what will BPD become? Early Human Develop 2012;8852:527–8
   Google Scholar
• Bose C, Van Marter LJ, Laughon M, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009;124:e450–8
   PubMed Web of Science ®Google Scholar
• Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. Pediatrics 2001;107:e1
   PubMed Web of Science ®Google Scholar
• Shinwell ES, Reichman B, Lerner-Geva L, et al., in collaboration with the Israel Neonatal Network. “Masculinizing” effect on respiratory morbidity in girls from unlike-sex preterm twins: a possible transchorionic paracrine effect. Pediatrics 2007;120:e447–53
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;19:CD004454
   Google Scholar
• Klinger G, Sokolover N, Boyko V, et al. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants. Am J Obstet Gynecol 2013;208:115.e1–9
   Google Scholar
• Durrmeyer X, Kayem G, Sinico M, et al. Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: a pregnancy disorder-based approach. J Pediatr 2012;160:578–83.e2
   PubMed Web of Science ®Google Scholar
• Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8:73–81
   PubMedGoogle Scholar
• Kaminsky DA, Irvin CG, Sterk PJ. Complex systems in pulmonary medicine: a systems biology approach to lung disease. J Appl Physiol (1985). 2011;110:1716–22
   Google Scholar
• Fanos V, Antonucci R, Barberini L, et al. Clinical application of metabolomics in neonatology. J Matern Fetal Med 2012;25:104–9
   Google Scholar
• Atzori L, Antonucci R, Barberini L, et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci 2011;3:1005–12. [Elite Edition]
   Google Scholar
• Fanos V, Antonucci R, Barberini L, Atzori L. Urinary metabolomics in newborns and infants. Adv Clin Chem 2012;58:194–218
   Web of Science ®Google Scholar
• Fanos V, Chevalier RL, Faa G, Cataldi L. Developmental nephrology: from embryology to metabolomics. Quartu S. Elena, Italy: Hygeia Press; 2011
   Google Scholar
• Atzori L, Antonucci R, Barberini L, et al. 1H NMR-based metabolomic analysis of urine from term and preterm neonates. Front Biosci (Elite Ed) 2011;3:1005–12
   PubMedGoogle Scholar
• Mussap M, Antonucci R, Noto A. The role of metabolomics in neonatal and pediatric laboratory medicine. Clin Chim Acta 2013;426:127–38
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181–9
   PubMed Web of Science ®Google Scholar
• Fanos V, Locci E, Noto A, et al. Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. Early Human Develop 2013; 89S1:S58–61
   Google Scholar
• Issaq HJ, Van QN, Waybright TJ. Analytical and statistical approaches to metabolomics research. J Sep Sci 2009;32:2183–99
   PubMed Web of Science ®Google Scholar
• Wold S, Antti H, Lindgren F, Ohman J. Orthogonal signal correction of nearinfrared spectra. Chemometr Intell Lab Syst 1998;44:175–85
   Web of Science ®Google Scholar
• Beckwith-Hall BM, Brindle JT, Barton RH, et al. PLS and related methods. In: Vinzi VE, Lauro C, Morineau A, Tenenhaus M, eds. Proceedings of the PLS’01 International Symposium. Paris, France: Centre International de Statistique et d’Information Appliques; 2001
   Google Scholar
• Hauksson JB, Edlund U, Trygg J. NMR processing techniques based on multivariate analysis. Magn Reson Chem 2001;39:267–75
   Google Scholar
• Chesney RW, Han X, Patters AB. Taurine and the renal system. J Biomed Sci 2010;17:S4
   Google Scholar
• Dessi A, Fanos V. Myoinositol: a new marker of intrauterine growth restriction? Obstet Gynaecol 2013;33:776–80
   Google Scholar
• Mimmi MC, Ballico M, Nakib G, et al. Altered metabolic profile in congenital lung lesions revealed by 1H nuclear magnetic resonance spectroscopy. An Chem 2014;2014: Article ID 391836, 8 pages
   Google Scholar
• Ma S, Shien LI, Huang CC. High-resolution proton nuclear magnetic resonance studies of urine from aspyxiated newborns. Appl Biochem Biotechnol 1995;53:37–46
   Google Scholar
• Phypers, B J, Pierce JMT. Lactate physiology in health and disease. Contin Educ Anaesthesia Crit Care Pain 2006;6:128–32
   Google Scholar
• Satoh H. Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects. Adv Exp Med Biol 1994;359:181–96
   PubMedGoogle Scholar
• Stipanuk M. Homocysteine, cystein and taurin. In: Shils ME, Shike M, Ross CA, et al, eds. Modern nutrition in health and disease. Baltimore: Lippincot Williams & Wilkins; 2006:545–62
   Google Scholar
• de Boo HA, Harding JE. Taurine as a marker for foetal wellbeing? Neonatology 2007;91:145–54
   Google Scholar
• Foxall PJ, Mellotte GJ, Bending MR, et al. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993;43:234–45
   PubMed Web of Science ®Google Scholar
• Le Moyec L, Pruna A, Eugène M, et al. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993;65:433–9
   PubMedGoogle Scholar
• Bairaktari E, Seferiadis K, Liamis G, et al. Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine. Clin Chem 2002;48:1106–9
   PubMed Web of Science ®Google Scholar
• Faure JP, Jayle C, Dutheil D, et al. Evidence for protective roles of polyethylene glycol plus high sodium solution and trimetazidine against consequences of renal medulla ischaemia during cold preservation and reperfusion in a pig kidney model. Nephrol Dial Transplant 2004;19:1742–51
   Google Scholar
• Foxall PJ, Bewley S, Neild GH, et al. Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy. Arch Dis Child Fetal Neonatal Ed 1995;73:F153–7
   Google Scholar
• Bhargava R, Altmann CJ, Andres-Hernando A, et al. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-α antibodies. PLoS ONE 2013;8:e79037
   Google Scholar
• de Abreu KL, da Silva Junior GB, Muniz TD, et al. Acute kidney injury in critically ill patients with lung disease: kidney-lung crosstalk. Rev Bras Ter Intensiva 2013;25:130–6 [Article in English, Portuguese]
   Google Scholar
• Askenazi DJ, Koralkar R, Levitan EB, et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res 2011;70:302–6
   PubMed Web of Science ®Google Scholar
• Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005;147:786–90
   PubMed Web of Science ®Google Scholar
• Guimarães H, Rocha G, Guedes M, et al. Nutrition of preterm infants with bronchopulmonary dysplasia after hospital discharge – Part I. J Pediatr Neonat Individual Med 2014;3:e030116
   Google Scholar
• Guimarães H, Rocha G, Guedes MB, et al. Nutrition of preterm infants with bronchopulmonary dysplasia after hospital discharge – Part II. J Pediatr Neonat Individual Med 2014;3:e030117
   Google Scholar
• Fanos V. Cells, the tree, medicines and the tailor. Curr Pharm Des 2012;18:2995–6
   PubMed Web of Science ®Google Scholar
• Shaw GM, O'Brodovich HM. Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 2013;37:85–93
   PubMed Web of Science ®Google Scholar
• Herriges M1, Morrisey EE. Lung development: orchestrating the generation and regeneration of a complex organ. Development 2014;141:502–13
   PubMed Web of Science ®Google Scholar
• Carraro S, Filippone M, Da Dalt L, et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev 2013;89:S3–5
   PubMed Web of Science ®Google Scholar